Filing Details
- Accession Number:
- 0001209191-16-138764
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-26 13:51:55
- Reporting Period:
- 2016-08-24
- Filing Date:
- 2016-08-26
- Accepted Time:
- 2016-08-26 13:51:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-24 | 6,500 | $36.30 | 274,725 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-08-24 | 1,100 | $96.73 | 273,625 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-08-24 | 1,000 | $98.74 | 272,625 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-08-24 | 100 | $99.50 | 272,525 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-08-24 | 1,500 | $101.21 | 271,025 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-08-24 | 2,800 | $101.83 | 268,225 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-08-24 | 100 | $100.02 | 79,100 | No | 4 | S | Indirect | Common Stock Held In Trust |
| Common Stock | Disposition | 2016-08-24 | 900 | $101.60 | 78,200 | No | 4 | S | Indirect | Common Stock Held In Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | Common Stock Held In Trust |
| No | 4 | S | Indirect | Common Stock Held In Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-08-24 | 6,500 | $0.00 | 6,500 | $36.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 131,500 | 2017-01-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,286 | Indirect | 401k |
Footnotes
- Transaction made pursuant to the holder's company approved trading plan under Rule 10b5-1.
- The holder undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $96.73 (range $96.40 to $97.37).
- Open market sales reported on this line occurred at a weighted average price of $98.74 (range $98.37 to $99.19).
- Open market sales reported on this line occurred at a weighted average price of $101.21 (range $100.63 to $101.60).
- Open market sales reported on this line occurred at a weighted average price of $101.83 (range $101.63 to $102.45).
- Open market sales reported on this line occurred at a weighted average price of $101.60 (range $101.25 to $102.00).
- Fully vested.
Billionaire Hedge Funds
